EPCAM and Alzheimer disease: It was discovered that mice with AD exhibited reduced expression of Epcam, Ephb3, and ZO-1, but increased expression of IL-1β compared to control (Figures 5B–E), suggesting the impairment of intestinal barrier function and the development of intestinal inflammation.